REG - McBride PLC - Correction - Result of General Meeting

McBrideAnnouncement

25/08/2022 18:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220825:nRSY2941Xa&default-theme=true

RNS Number : 2941X  McBride PLC  25 August 2022

The following announcement replaces the announcement released on 25 August
2022 at 16:40 under RNS number 2800X.  Changes have been made to replace any
references to 'Annual General Meeting' or 'AGM' with 'General Meeting'. All
other details remain unchanged.

 

The full amended text is shown below.

 

 

 

 

25 August 2022

 

Result of General Meeting

 

 

 

Following the General Meeting held today, 25 August 2022, McBride plc (the
Company) is pleased to announce that the resolution set out in the circular
dated 9 August 2022 was passed. The results of the poll vote for the
resolution are as follows:

 

    Votes For    %      Votes Against  %     Votes Withheld  Votes Total
 1  130,314,520  99.98  32,093         0.02  5,777           130,352,390

 

Note:      A vote withheld is not a vote in law and is not counted in
calculating votes for or against a resolution.

 

The total number of voting rights as at 23 August 2022 was 174,015,287
Ordinary shares of 10p each.

 

In accordance with Listing Rules 9.6.2 R, copies of the resolutions passed at
the General Meeting have been submitted to the Financial Conduct Authority's
National Storage Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) :

 

The documents can also be obtained via the Company's website www.mcbride.co.uk

 

For further enquiries:

Glenda MacGeekie, Chief Legal Officer & Company Secretary     +44
(0)161 203 7432

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMPAMRTMTBTBPT